Abstract:Qiong Tang, Dai Gong, Xiao-Min Ye, Jun-Ru Xu, Yi-Can Yang, Li-Juan Yan, Li Zou, Xiang-Lan Wen Department of Children Health Care Center, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, Zhuzhou, People's Republic of China Correspondence: Xiang-Lan Wen, Department of Children Health Care Center, Zhuzhou Hospital Affiliated to Xiangya Medical College, Central South University, No. 116 of Changjiang South Road, Tianyuan District, Zhuzhou City, Hunan Province, 412007, People's Republic of China, Tel +86 13873317331, Email Craniofacial dysmorphism, cardiac abnormalities, ectodermal abnormalities, psychomotor delay, intellectual disability, and short stature are all hallmarks of the extremely rare disorder known as cardiofaciocutaneous syndrome (CFCS). Although CFCS is considered rare, approximately 300 cases have been documented in the literature. In this report, we discuss a patient diagnosed with CFCS without the typical heart malformations but with craniofacial features, skin abnormalities, intellectual disability, and short stature. Genetic testing revealed the presence of three potentially harmful variants: one in the MAP2K1 gene and two in the ATP2B3 and CDC42BPB genes, the significance of which is currently not yet found. Our findings in this case report suggest that the clinical symptoms of CFCS may be atypical, thereby expanding our understanding of the symptom spectrum of the disease. Simultaneously, the link between the clinical symptoms of the patient and the two unknown pathogenic variants has not been established. This case report supplements existing clinical reference material by providing valuable insights into the specific scenario. Keywords: cardiofaciocutaneous syndrome, gene detection, intellectual disability, neurodevelopmental syndrome, short stature, spinocerebellar ataxia Cardiofaciocutaneous syndrome (CFCS) is an autosomal-dominant genetic disease of the renin-angiotensin system (RAS) cardiomyopathy group. This syndrome refers to a group of developmental disorders caused by the germline pathogenic variant of gene encoding RAS/Mitogen-activated protein kinase (MAPK) signaling pathway protein, and the pathogenic variant of four genes related to CFCS. These are BRAF (7q34), MAP2K1 (15q22.31), MAP2K2 (19p13.3, CFCS4, OMIM#615280), and KRAS (12p12.1), which encode the RAS protein (KRAS) and/or its downstream signals serine-threonine kinase ( BRAF, MEK1, MEK22 ). Among these, heterozygous pathogenic variants of BRAF gene are the most common, while MAP2K1, MAP2K2C2 , and KRAS genes are less involved. RAS cardiomyopathies include a wide variety of conditions, including Noonan syndrome (NS) and Costello syndrome (CS). 1–3 Therefore, CFCS is similar to NS and CS while also having its own unique characteristics. The clinical phenotypes of CFCS include craniofacial features, cardiac anomalies (most commonly atrial septal defect and pulmonary artery stenosis), hair and skin abnormalities, gastrointestinal dysfunction, neurocognitive delay, epilepsy, short stature, and slow weight gain. In addition, some patients lack immunoglobulins but exhibit no symptoms. 4 ATP2B3 and CDC42BPB play a key role in numerous cellular processes and physiological functions. ATP2B3 is involved in maintaining cellular calcium homeostasis, while CDC42BPB is a key regulator of actin cytoskeleton dynamics and cell migration. Both genes play critical roles in physiological processes and have been linked to diseases when their roles are disrupted. In addition to its distinctive clinical symptoms, CFCS can be distinguished from NS and CS by genetic testing. There are few published reports on CFCS due to the MAP2K1 gene pathogenic variant in China. In this report, we describe a patient who exhibited both classic and atypical symptoms of CFCS as a result of a pathogenic variant in the MAP2K1 gene. A two-year six-month-old boy was diagnosed with "slow growth in height and weight and developmental delay for more than two years". The child presented with a neurodevelopmental delay, an inability to sit independently, and no verbal communication; the child had a height of 78.6 cm (−3.7 SD) and weight of 8.34 kg (−3.9 SD) at the time of first visit. The child was born to a then 35-year-old G7P3 mom at the gestation age of 33 weeks and 4 days by a cesarian section due to premature rupture of membranes. The neonate measured 45 cm in length and weighed 2.35 kg. During pregnancy, fetal measurements showed that both the head and the abdomen circumferences were larger than normal for the gestational age, but no complications were seen in the neonatal period. The child was initially breastfed and introduced to complementary foods at s -Abstract Truncated-

Syndromic craniosynostosis caused by a novel missense variant in MAP4K4: Expanding the genotype–phenotype relationship in RASopathies

Integrated Facial Analysis and Targeted Sequencing Identifies a Novel KDM6A Pathogenic Variant Resulting in Kabuki Syndrome

Recurrent p.H119Y variant in MAP2K1 expands the phenotypic spectrum of MAP2K1‐related RASopathy

Abrogation of MAP4K4 protein function causes congenital anomalies in humans and zebrafish

[New Insight of Craniofacial and Oral Findings of the RASopathies].

Neurodevelopmental Aspects of RASopathies

Deletion of MAP2K2/MEK2: a novel mechanism for a RASopathy?

Loss-of-function variants in ERF are associated with a Noonan syndrome-like phenotype with or without craniosynostosis

Heterozygous MAP3K20 variants cause ectodermal dysplasia, craniosynostosis, sensorineural hearing loss, and limb anomalies

Bi-allelic CAMSAP1 variants cause a clinically recognizable neuronal migration disorder

ERF-related craniosynostosis: The phenotypic and developmental profile of a new craniosynostosis syndrome

Rare copy number variations containing genes involved in RASopathies: deletion of SHOC2 and duplication of PTPN11

Gain-of-function MARK4 variant associates with pediatric neurodevelopmental disorder and dysmorphism

Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort

The MAP3K7 gene: further delineation of clinical characteristics and genotype/phenotype correlations

The First Korean Case with Cardiac, Facial, and Digital Anomalies with Developmental Delay Caused by De Novo TRAF7 p.Arg655Gln Variant

De Novo Variants in MAPK8IP3 Cause Intellectual Disability with Variable Brain Anomalies

Expanding mutational spectrum of HRAS by a patient with Schimmelpenning-Feuerstein-Mims syndrome

RASopathies influences on neuroanatomical variation in children.

Cardiac Manifestations and Associations with Gene Mutations in Patients Diagnosed with RASopathies

A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant